Detalles de la búsqueda
1.
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis.
N Engl J Med
; 384(13): 1227-1239, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33789011
2.
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 400(10349): 369-379, 2022 07 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35908570
3.
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.
Lancet
; 399(10341): 2113-2128, 2022 06 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644166
4.
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis.
N Engl J Med
; 383(16): 1511-1521, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33053283
5.
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.
Lancet
; 397(10290): 2151-2168, 2021 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023008
6.
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial.
Ann Rheum Dis
; 81(11): 1515-1523, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35788492
7.
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.
Gastroenterology
; 158(8): 2123-2138.e8, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32044319
8.
Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2.
Ann Rheum Dis
; 80(3): 312-320, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33272960
9.
Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial.
J Allergy Clin Immunol
; 145(3): 877-884, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31786154
10.
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study.
Mod Rheumatol
; 31(3): 534-542, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33164611
11.
Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study.
Lancet
; 393(10188): 2303-2311, 2019 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31130260
12.
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial.
Lancet
; 394(10214): 2108-2117, 2019 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31732180
13.
Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study.
Rheumatology (Oxford)
; 59(11): 3303-3313, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32277824
14.
Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial.
Lancet
; 391(10139): 2513-2524, 2018 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29908670
15.
Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet
; 391(10139): 2503-2512, 2018 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29908669
16.
Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study.
Lancet
; 392(10142): 134-144, 2018 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29961640
17.
Non-radiographic axial spondyloarthritis patients without initial evidence of inflammation may develop objective inflammation over time.
Rheumatology (Oxford)
; 56(7): 1162-1166, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28387855
18.
A psychometric analysis of outcome measures in peripheral spondyloarthritis.
Ann Rheum Dis
; 75(7): 1302-7, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26245756
19.
ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis.
Rheumatology (Oxford)
; 55(1): 80-8, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26316575
20.
Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab.
Rheumatology (Oxford)
; 54(7): 1210-9, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25541333